References
Lu W, Lu C, Yu Z, Gao L. Chemoradiotherapy alone vs chemoradiotherapy and hysterectomy for locally advanced cervical cancer: a systematic review and updated meta-analysis. Oncol Lett. 2021;21:160.
Ferrandina G, Margariti PA, Smaniotto D, et al. Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol. 2010;119:404–10.
Federico A, Pedone Anchora L, Gallotta V, et al. Clinical impact of pathological residual tumor in locally advanced cervical cancer patients managed by chemoradiotherapy followed by radical surgery: a large, multicenter, retrospective study. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11583-4
Nilsen A, Hillestad T, Skingen VE, et al. miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer. Mol Oncol. 2022;16(6):1402–1419. https://doi.org/10.1002/1878-0261.13184
Someya M, Fukushima Y, Hasegawa T, et al. Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immuno radiotherapy. Jpn J Radiol. 2022. https://doi.org/10.1007/s11604-021-01231-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Federico, A., Anchora, L.P., Scambia, G. et al. ASO Author Reflections: Role of Adjuvant Surgery in Locally Advanced Cervical Cancer: An Unresolved Issue. Ann Surg Oncol 29, 4815–4816 (2022). https://doi.org/10.1245/s10434-022-11620-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11620-2